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Possible involvement of NEDD4 in keloid formation; its critical role
in ﬁbroblast proliferation and collagen production
By Suyoun CHUNG,*1 Mitsuko NAKASHIMA,*1 Hitoshi ZEMBUTSU*1 and Yusuke NAKAMURA*1,†
(Communicated by Kumao TOYOSHIMA, M.J.A.)
Abstract: Keloid represents overgrowth of granulation tissue, which is characterized by
collection of atypical ﬁbroblasts with excessive deposition of extracellular matrix components, after
skin injury, but its etiology is still largely unknown. We recently performed genome-wide association
study (GWAS) of keloid and identiﬁed NEDD4 to be one of candidate molecules associated with
keloid susceptibility. Here we demonstrate a possible mechanism of NEDD4 involvement in keloid
formation through enhancement of the proliferation and invasiveness of ﬁbroblasts as well as
upregulation of type 1 collagen expression. Activation of NEDD4 aﬀected subcellular localization
and protein stability of p27 which was implied its critical role in contact inhibition. It also induced
accumulation of O-catenin in the cytoplasm and activated the TCF/O-catenin transcriptional
activity. Furthermore, NEDD4 upregulated expressions of ﬁbronectin and type 1 collagen and
contributed to the excessive accumulation of extracellular matrix. Our ﬁndings provide new insights
into mechanism developing keloid and can be applied for development of a novel treatment for
keloid.
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Introduction
Wound healing and tissue regeneration are
important for maintenance of the tissue homeostasis
and regulated very strictly by various factors.
Dysregulation of this system in skin can lead to
hyperproliferative scar formation such as hyper-
trophic scars and keloids. Keloid is clinically deﬁned
as skin trauma growing beyond the conﬁnes of
original wounds and shows no tendency of regression
over time.1),2) These lesions are often accompanied
with severe pain, intolerable itching, and cosmetic
disﬁgurement, which can signiﬁcantly impair quality
of life (QOL) of patients both physically and
psycologically.3)
The formation of keloid is more common among
individuals with a darker pigmented skin.1)–4) Famil-
ial occurrence is also reported although most of the
cases are observed sporadically. In a study of 14
pedigrees with familial keloid, the inheritance pattern
is consistently autosomal dominant with incomplete
clinical penetrance and variable expressions.5) These
studies implicated that the involvement of genetic
factors in the development of keloid formation.
Although TGF-O and SMAD have been implicated
their involvement in keloid pathogenesis,6)–12) pre-
vious association studies failed to demonstrate any
positive associations of polymorphisms in genes
belonging to the TGF-O and SMAD families with
keloid susceptibility.1),13)–16) Despite of many chal-
lenges to elucidate the keloid pathogenesis, there
have been no clear evidences explaining the molecular
mechanism for keloid formation.
To clarify genetic factors associated with sus-
ceptibility to keloid and elucidate the molecular
mechanisms for keloid formation, we recently per-
formed a genome-wide association study (GWAS) for
keloid disease and identiﬁed four susceptibility loci in
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rs8032158, that is located in intron 5 of the neuronal
precursor cell-expressed developmentally downregu-
lated 4 (NEDD4) gene on chromosome 15, showed
very signiﬁcant association with keloid (P F 1.95 #
10!11;O RF 1.49 with 95%CI of 1.33–1.67), implying
the possible involvement of NEDD4 in the keloid
pathogenesis. NEDD4 is characterized as an E3
ubiquitin ligase with a HECT domain, involved in
ubiquitin-mediated protein degradation.18) Ubiquiti-
nation regulates protein turnover in cells by regulat-
ing the degradation of speciﬁc proteins. The E3
ligases play a critical role in the ubiquitin conjugation
cascade by recruiting ubiquitin-conjugating enzyme
E2, recognizing speciﬁc substrates, and facilitating or
directly catalyzing ubiquitin transfer to their target
molecules.19),20) The relevance of the E3 ligases in
several biological processes is demonstrated in vivo
by the facts that their genetic alteration, abnormal
expression, or dysfunction is often accompanied with
pathological disorders including cancer.20)
Here we report the biological role of E3 ubiquitin
ligase NEDD4 in keloid pathogenesis by regulation of
ﬁbroblast proliferation and migration through ubiq-
uitination of PTEN. Loss of PTEN in ﬁbroblasts is
likely to induce cell cycle progression and cell
migration through regulation of the Akt pathway.
NEDD4-mediated Akt activation altered protein
expression or subcellular localization of O-catenin
and p27. Furthermore, NEDD4 in ﬁbroblasts in-
volved in the regulation of collagen and ﬁbronectin
expression. This aberrant regulation caused the
accumulation of collagen and ﬁbronectin in extra-
cellular matrix. These results suggested that NEDD4
could contribute to the keloid formation and
progression.
Materials and methods
Cell Lines. NIH3T3 cells and keloid ﬁbroblasts
were purchased from the American Type Culture
Collection (ATCC, Rockvill, MD). Normal Human
Dermal Fibroblast (NHDF) and normal Human
Epithelial Keratinocyte (NHEK) were purchased
from Lonza (Walkersvill, MD). NIH3T3 cells and
keloid ﬁbroblasts were grown in Dulbecco’s modiﬁed
Eagle’s medium (Invitrogen, Carlsbad, CA; ATCC);
the media were supplemented with 10% bovine serum
(GIBCO, Grand Island, NY) for NIH3T3 cells, with
10% fetal bovine serum (Nichirei Bioscience Inc.,
Tokyo, Japan) and 1% antibiotic/antimycotic solu-
tion (Sigma-Aldrich, St. Louis, MO) for keloid
ﬁbroblasts. NHDF and NHEK were cultured with
appropriate media according to the manufacturer’s
recommendation. Cells were maintained at 37°C in
atmospheres of humidiﬁed air with 5% CO2.
Semi-quantitative RT-PCR. Total RNAs
from cells were extracted using RNeasy Kit
(QIAGEN, Valencia, CA) according to manufac-
turer’s recommendation. Extracted RNAs were
treated with RNase-Free DNase Set (QIAGEN) and
reversely transcribed to single-stranded cDNAs using
d(T)12-18 primer with Superscript II reverse tran-
scriptase (Invitrogen). The RT-PCR exponential
phase was determined to allow semi-quantitative
comparisons among cDNAs developed from identical
reactions. Each PCR regime involved a step of 95°C,
30sec initial denaturation followed by 22 cycles
(for ACTB), 25 cycles (for cyclinD1, COL1, COL3,
ﬁbronectin) and 30 cycles (for NEDD4, MMP7)o fa
step at 95°C for 10sec and 56°C for 30sec and a step
of 72°C for 30sec (for ACTB, cyclinD1, MMP7,
COL1, COL3, ﬁbronectin) or 3min (for NEDD4),
on a Gene Amp PCR system 9600 (PE Applied
Biosystems, Foster, CA). The PCR using the
following primer sets; 5′-AAATGGCAACTTGCG-
CGGT-3′,5 ′-CTAATCAACTCCATCAAAGCC-3′
for NEDD4;5 ′-AATGTTAAACTCCCGCGTCA-3′
and 5′-TGGGGATCTCCATTTCCATA-3′ for
MMP7;5 ′-ATGGAACACCAGCTCCTGTG-3′ and
5′-TCAGATGTCCACGTCCC-3′ for cyclinD1;5 ′-
GTGCTAAAGGTGCCAATGGT-3′ and 5′-CTCC-
TCGCTTTCCTTCCTCT-3′ for COL1;5 ′-TACGG-
CAATCCTGAACTTCC-3′ and 5′-GTGTGTTTC-
GTGCAACCATC-3′ for COL3;5 ′-GGAGTTGA-
TTATACCATCACTG-3′ and 5′-TTTCTGTTTG-
ATCTGGACCT-3′ for ﬁbronectin;5 ′-TTGGCTTG-
ACTCAGGATTTA-3′ and 5′-ATGCTATCACCT-
CCCCTGTG-3′ for ACTB.
Immunoblotting. The cells were transfected
with NEDD4 expression vector or control mock
vector using Fugene 6 (Roche, Indianapolis, IN)
according to the manufacturer’s recommended pro-
cedures. We synthesized siRNA duplex (sense; 5′-
GUAUGAGUUCUUCCGAAGATT-3′, anti-sense;
5′-UCUUCGGAAGAACUCAUACTT-3′) for knock-
down of NEDD4 and transfected with Lipofectamine
RNAiMAX (Invitrogen) according to the manufac-
turer’s recommended procedures. Cells lysed in the
RIPA buﬀer that contained 1mM sodium orthova-
nadate, 10mM sodium ﬂuoride and protease inhib-
itor cocktail (Calbiochem, Darmstadt, Germany).
For analysis of secreted ﬁbronectin, conditioned
culture media were collected after 96 or 120h
incubation and concentrated using UltraFree centri-
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collagen analysis, cells were directly added 5# sample
buﬀer and collected. Protein from each sample was
separated by SDS-PAGE and transferred to nitro-
cellulose membranes. Membranes were incubated
with the indicated primary antibodies; anti-Flag,
anti-ACTB (Sigma-Aldrich), anti-NEDD4, anti-
PTEN, anti-O-catenin, anti-p27, anti-COL1A1,
anti-ﬁbronectin (Santa Cruz Biotechnology, Santa
Cruz, CA), anti-phospho-GSK3O (Ser9), anti-Akt,
anti-phospho-Akt (Ser473) (Cell signaling, Beverly,
MA) antibodies.
Cell viability assay. The full length of NEDD4
cDNA (NP_006145) was prepared by PCR ampliﬁ-
cation and inserted into pcDNA3.1-myc-his vector
(invitrogen). The plasmid was transfected into
NHDF cells using Fugene6 (Roche) according to
the manufacturer’s recommended procedures. For
in vitro growth assay, 1 # 104 NHDF cells, in which
NEDD4 was exogenously introduced, were seeded
into each wells of a 48-well culture plate and
incubated in their respective recommended media
for 48h. The growth curve of these established clones
were measured using Cell-counting kit-8 (DOJINDO,
Kumamoto, Japan).
Matrigel invasion assay. NIH3T3 cells that
were transfected with either plasmid designed to
express NEDD4 (pcDNA3.1/NEDD4-Myc-His) or
that with mock plasmid were grown to the near
conﬂuence condition in DMEM containing 10% BS.
For Matrigel invasion assay, 1 # 104 cells were plated
in the top chamber with Matrigel-coated membrane
(BD Labware, Bedford, MA). Cells were plated in
serum-free medium, and medium with serum was
used as a chemoattractant in the lower chamber. The
cells were incubated for 20h and cells which did not
invade were removed by a cotton swab. The cells
invading through Matrigel were ﬁxed and stained
with Gimsa (Merck, Darmstadt, Germany) and
counted.
Multi-layer cell culture and colony forma-
tion. NIH3T3 cells were seeded onto 6-cm dish and
transfected with control empty vector or NEDD4
expression vector. Cells were cultured until over
100% conﬂuent condition, then photographed and
stained with Giemsa staining solution (Merck) at 7
days after reaching to the conﬂuent level.
Immunocytochemical staining. Cells were
transfected with NEDD4 expression vector
(pCAGGS/NEDD4-HA) as described above and
incubated for 48h. After the incubation, the cells
were ﬁxed with methanol:acetone for 1h at !20°C.
Non-speciﬁc binding was blocked by treatment with
PBS containing 3% BSA for 60min at room temper-
ature. The cells were incubated for 60min at room
temperature with each of the indicated primary
antibodies (anti-HA (Roche), anti-O-catenin and
anti-p27 as described above) diluted at 1:200 by
PBS containing 3% BSA. After washing with PBS,
the cells were stained by the FITC-conjugated
secondary antibody (invitrogen) for 60min at room
temperature and visualized with Spectral Confocal
Scanning Systems (Leica, Heidelberg, Germany).
Recombinant proteins and in vitro ubiquiti-
nation assay. The full length cDNAs of human
NEDD4 (900 amino acids, NP_006145) and human
PTEN (403 amino acids, NP_000305) were prepared
by PCR ampliﬁcation and inserted into pGEX-6P-3
vector (GE Healthcare Bio-sciences, Piscataway,
NJ). The recombinant NEDD4 or PTEN that was
fused with glutathione S-transferase (GST) tag at N-
terminus was expressed in Escherichia coli, BL21
codon plus (Stratagene, La Jolla, CA), and puriﬁed
with Glutathione Sepharose 4B and PreScission
protease (GE Healthcare Bio-sciences) under native
condition according to supplier’s protocol. For
in vitro ubiquitination assay, the NEDD4 and PTEN
proteins were incubated with E1 and E2 (UbcH7)
enzymes, and ubiquitin in the assay buﬀer of
Ubiquitylation kit (ENZO Life Sciences, Farming-
dale, NY). After 2h of incubation at 30°C, the
reactions were terminated by addition of SDS sample
buﬀer.
Statistical analysis. All values were presented
as means ’ s.d. Statistical signiﬁcance was computed
using Student’s t-test, and the level of signiﬁcance
was set at P < 0.05.
Results
NEDD4 contributed to loss of the cell–cell
contact inhibition by promoted cell proliferation
and invasiveness. NEDD4 was reported its
abundant expression in skeletal muscle, placenta,
and cancer cell lines.21) Because NEDD4 was
identiﬁed as a candidate gene susceptible to the
keloid disease in our GWAS analysis,17) we suspected
that genetic variations on this locus might contribute
to its expression level. Hence, we ﬁrst examined the
expression of NEDD4 in ﬁbroblasts, and found that
NEDD4 was expressed in skin, normal ﬁbroblast
cell lines as well as keloid ﬁbroblasts (Fig. 1A). To
investigate the biological role of NEDD4 in keloid
formation, we constructed a plasmid vector that was
designed to express human NEDD4 and transfected
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cells. The cells were incubated for 48h and the
number of the cells was measured by an MTT assay,
suggesting that the over-expression of NEDD4
promoted the growth of the NHDF cells (Fig. 1B).
The pathological features of human keloid tissue
are characterized by the increased density and
proliferative rate of ﬁbroblasts, and their aggressive
invasion ability to the normal surrounding skin
tissue.1) To examine a possible role of NEDD4 in
the cellular invasiveness, we performed a Matrigel
invasion assay using NIH3T3 ﬁbroblast cells. As
shown in Fig. 1C, NEDD4 over-expression drasti-
cally increased the invasive ability of NIH3T3 cells.
Furthermore, NIH3T3 cells which exogenously ex-
pressed NEDD4 were multi-layered and formed
colonies after they reached to the 100% conﬂuence
stage in the dish while we did not observe any colony
formation in the control mock cells (Fig. 1D, E).
These data imply that NEDD4 promoted keloid
ﬁbroblast proliferation and inﬁltration into the
surrounding skin tissues, and deregulated the contact
inhibition after cell–cell attachment.
Over-expression of NEDD4 increased cyto-
plasmic p27 and promoted its degradation. To
further investigate how NEDD4 promotes the cell
proliferation and invasiveness of ﬁbroblast cells, we
examined molecules involved in the cell-cycle pro-
gression and the epithelial-mesenchymal transition
(EMT). A cyclin-dependent kinase inhibitor p27 is
known to be involved in contact inhibition by
inducing the cell cycle arrest.22),23) Phosphorylation-
dependent degradation of the p27 protein aﬀected
the contact inhibition process.24),25) To investigate
roles of NEDD4 over-expression on p27 degradation
and/or its subcellular localization, we performed
immunocytochemical analysis and immunoblotting
using NIH3T3 cells that were transfected with
NEDD4 expression vector. We observed diﬀuse
staining of p27 in the cytoplasm of the cells over-
Fig. 1. Biological function of NEDD4 in human normal ﬁbroblasts. (A) NEDD4 was expressed in normal human skin, normal human
dermal ﬁbroblasts (NHDF), human keratinocytes (NHEK) and keloid ﬁbroblast, respectively. O-actin (ACTB) was used for
quantitative normalization. (B) Cell viability assay showing that NEDD4 promoted cell proliferation. MTT assay of NHDF cells that
were transfected with NEDD4 expression vector or the control mock vector. ABS on Y-axis means absorbance at 490nm with that at
630nm as a reference measured with a microplate reader. These experiments were carried out in triplicate (*P F 0.0001). (C) NEDD4
over-expressing NIH3T3 cells promoted cell invasion by Matrigel invasion assay. Invasion index means the average cell number of
migration, counted by microscopic observation. These experiments were carried out in triplicate (**P F 0.0235). Error bars represent
mean ’ s.d. (D, E) NEDD4 introduced NIH3T3 cells were multi-layered after cells reached 100% conﬂuent (D) and formed colonies
(E), whereas these were not observed in control mock cells.
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the nucleus of the parental NIH3T3 cells (Fig. 2A).
We also detected the decrease of the p27 protein level
in NEDD4-introduced cells (Fig. 2B), suggesting
that NEDD4 over-expression induced translocation
of p27 from nucleus to cytoplasm and enhanced its
degradation.
O-catenin signaling pathway was activated in
NEDD4 exogenously expressed ﬁbroblasts. We
also investigated the involvement of GSK3O/O-
catenin signaling pathway because O-catenin is
known to play a critical role in the EMT process
and contact inhibition.26)–28) O-catenin was reported
to be accumulated in hyperplastic scars as well as
keloid tissues.29) As shown in Fig. 3A, we indeed
observed O-catenin accumulation in keloid ﬁbro-
blasts. To clarify a possible role of NEDD4 in
regulation of O-catenin, we examined the phosphor-
ylation level of GSK3O and the amount of O-catenin
protein in the NIH3T3 cells which were transfected
with NEDD4 expression vector. Western blot analy-
sis indicated that the level of GSK3O phosphorylation
and the amount of O-catenin were signiﬁcantly
increased by exogenous induction of NEDD4. On
the other hand, knockdown of NEDD4 expression in
keloid ﬁbroblasts by NEDD4-speciﬁc siRNA duplex
reduced the amount of O-catenin (Fig. 3B). Immu-
nocytochemical staining found O-catenin to be
localized mainly in the cytoplasm in NEDD4 over-
expressing cells (Fig. 3C). The cytoplasmic O-catenin
is known to be translocated into the nucleus, binds
to TCF/LEF-1 transcriptional factors,30) and induce
the expression of several downstream genes such as
cyclin D1 and MMP7 which are reported to be up-
regulated during EMT.31),32) Hence, we performed
semi-quantitative RT-PCR using cDNA isolated
from NEDD4 over-expressing or NEDD4 knocked-
down cells, and observed that the expression levels of
MMP7 and cyclin D1 were reduced in the NHDF
cells in which NEDD4 expression was knocked-down,
while they were elavated in the cells in which NEDD4
was over-expressed (Fig. 3D).
NEDD4 activated Akt signaling transduc-
tion through dysregulation of PTEN. NEDD4 is
characterized as an E3 ubiquitin ligase with a HECT
domain, involved in ubiquitin-mediated protein
degradation.18) Recently, NEDD4 was demonstrated
to directly ubiquitinate PTEN (phosphatase and
tensin homolog deleted on chromosome 10) and
regulate its stability.33),34) p27 and O-catenin are
known to be targets of the Akt protein which is
regulated by PTEN. Interestingly, germline PTEN
Fig. 2. The regulation of p27 in NEDD4 over-expressing cells. (A) Immunocytochemical analysis reveals the diﬀuse subcellular
localization of p27 in the cytoplasm in the cells in which NEDD4 was exogenously introduced while most of the p27 protein was
localized in the nucleus in the control cells in which NEDD4 was not introduced. Nuclei were stained with DAPI. Bar F 17µm.
(B) The protein expression of p27 was decreased in NEDD4 over-expressed cells rather than mock cells.
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drome, also known as PTEN hamartoma tumor
syndrome (PHTS), and the patient of PHTS tends to
form keloids.35),36) Hence, we performed in vitro
ubiquitination assay using human NEDD4 and
PTEN recombinant proteins. We incubated them
with E1 and E2 enzymes, and examined the
ubiquitination of PTEN by anti-Ub antibody. The
ubiquitination of PTEN was detected in the presence
of the NEDD4 recombinant protein, while it was not
without NEDD4 (Fig. 4A). Subsequently, we also
found that the drastic reduction of the PTEN protein
level in NEDD4 over-expressing cells, compared
with the parental cells, by western blot analysis
(Fig. 4B).
The activated/phosphorylated Akt was reported
to phosphorylate many substrates including p27
and GSK3O, and to promote growth and migration
of cells.37)–39) Since PTEN is known to negatively
regulate the PI3K/Akt pathway,37),40) we examined
the phosphorylation level of Akt in the NEDD4 over-
expressing NIH3T3 cells. The phosphorylated Akt
level was increased in the NEDD4 over-expressing
cells, in concordance with the reduction of the
amount of PTEN protein (Fig. 4C). Therefore, we
suspected that NEDD4 enhances proliferative and
invasive properties of cells through dysregulation of
the PTEN/PI3K/Akt signaling pathway.
NEDD4 regulated the expression of ﬁbro-
nectin and type 1 collagen in ECM of ﬁbronectin.
The excessive deposition of collagen in extracellular
matrix (ECM) is another clinical characteristic of
keloid disease.1) To elucidate this accumulation
of collagen and other ECM-related molecules, we
Fig. 3. NEDD4 increased cytoplasmic O-catenin and upregulated O-catenin transcriptional activity. (A) Up-regulation of O-catenin in
keloid ﬁbroblasts. Endogenous O-catenin was detected by western blot analysis using total cell lysates. NHDF; normal human dermal
ﬁbroblast, NHEK; normal human epithelial keratinocyte, short; short exposure, long; long exposure. (B) Phospho-GSK3O and O-
catenin were up-regulated in the cells that NEDD4 was transiently introduced. The cells were incubated for 48h or 72h after the
transfection. Depletion of NEDD4 in keloid ﬁbroblasts decreased the protein level of O-catenin. The cells were incubated for 48h after
the transfection of siRNA duplex. (C) Immunocytochemical staining detected O-catenin mainly at plasma membrane in the cells in
which NEDD4 was not introduced while O-catenin was translocated to the cytoplasm in NEDD4 over-expressing cells. Bar F 12µm.
(D) Transcriptional changes of the genes regulated in the O-catenin/TCF were analyzed by semi-quantitative RT-PCR. Cells were
incubated for 72h (for transiently expressing) or 96h (for knockdown). O-actin (ACTB) was used to quantify cDNA contents.
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for their relation to the NEDD4. As shown in
Fig. 5A, RT-PCR experiments revealed that expres-
sion of type I and III collagen was decreased in NHDF
cells in which NEDD4 was knocked down, compared
with control cells. The transcriptional level of
ﬁbronectin was also decreased in NEDD4-depleted
cells (Fig. 5A). In addition, by western blot analysis
using the conditioned medium, we found that the
secreted ﬁbronectin was drastically decreased in
NEDD4-knocked down NHDF cells as similar to the
intracellular ﬁbronectin (Fig. 5B). Subsequently, we
investigated the expression of collagen in NEDD4
over-expressing cells by western blot analysis. As
shown in Fig. 5C, type1 collagen (COL1A1) was
upregulated in the NEDD4 transiently expressed
NIH3T3 cells.
Discussion
In this study, we investigated for biological
functions of NEDD4, which was identiﬁed as one of
the genes susceptible to keloid through our recent
GWAS for keloid disease.17) Keloid ﬁbroblasts are
characterized by its hyperproliferative and invasive
nature.1) Since our data indicated that NEDD4 over-
expression in ﬁbroblasts promoted proliferation and
invasiveness of the cells through dysregulation of
the PTEN/Akt pathway, NEDD4 is very likely to
be involved in the abnormal process of the wound
healing.
NEDD4 is an E3 ubiquitin ligase containing a
HECT domain and PTEN was recently identiﬁed as
one of its substrates.33) PTEN was ﬁrst identiﬁed as a
tumor suppressor gene on human chromosome 10q23
and later its frequent inactivation in various types of
human cancer was reported.41),42) The functional
signiﬁcance of PTEN is also supported by its germ-
line mutations in patients with a group of autosomal
dominant syndromes characterized by developmental
disorders, multiple hamartomas and neurological
deﬁcits that are referred as PHTS.35),36),43) Cowden
disease, Bannayan–Riley–Ruvalcaba syndrome
(BRRS), Proteus syndrome and Proteus-like syn-
drome that belong to PHTS are characterized by
occurrence of multiple tumor-like masses.35) Patients
with PHTS are well known to have high risk to
develop keloid disease after surgical operations or
injuries,36),43) implying a potential role of the PTEN
pathway in keloid formation. PTEN is a plasma
membrane lipid phosphatase that antagonizes pho-
phatidylinositol 3-kinase (PI3K)/Akt signaling.44)
Loss of PTEN activity leads to Akt activation that
can promote cell survival, proliferation, and invasion
through phosphorylation of many substrates includ-
ing MDM2, GSK3, and p27.37),44)
During wound healing process, p27 as well as
GSK3O/O-catenin are considered to be important
molecules for the cell–cell contact inhibition22),28)
that is a mechanism inhibiting the cell motility and
proliferation when cells reach to the high density
Fig. 4. NEDD4 activated Akt signaling pathway through diminished PTEN protein level in ﬁbroblasts. (A) In vitro ubiquitination assay
of PTEN by NEDD4. NEDD4 ubiquitinated PTEN directly. (B) NEDD4 ubiquitinated PTEN directly and promoted the protein
degradation. Immunoblot analysis for endogenous PTEN in NEDD4 over-expressing NIH3T3 cells. Control or NEDD4 expression
vector were transfected and incubated for 48h. O-actin (ACTB) was blotted as the loading control. (C) Over-expression of NEDD4 in
NIH3T3 cells enhanced the phosphorylation level of Akt. Control or NEDD4 expression vector were transfected and incubated for
48h. Phosphor-Akt and total Akt were detected by immunoblotting. O-actin (ACTB) was blotted as the loading control.
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inhibition process is implicated to be critically
important for development and tissue regeneration.
Failure of the contact inhibition is usually associated
with abnormal growth of cells and the appearance of
multilayered foci in culture, which are often observed
in the malignant transformation process.45),46) The
contact inhibition consists of two important proc-
esses, EMT and cell-cycle regulation. EMT is critical
for appropriate tissue remodeling and cell migration
during embryonic development, and is re-engaged in
adults during wound healing and tissues regenera-
tion. During EMT, O-catenin is up-regulated and
located in the cytoplasm and/or the nucleus.26)–28)
The nuclear O-catenin binds to T-cell factor/lym-
phoid enhancer binding factor (TCF/LEF) tran-
scription factors and activates transcription of their
target genes.30)–32),47) O-catenin is known to be
accumulated during ﬁbroproliferation, and was
shown its elevated expression in aggressive ﬁbroma-
tosis and keloid tissues.29),48) Cytoplasmic O-catenin
is degraded after it was phosphorylated by GSK3O,
which was shown to be phosphorylated and inacti-
vated by Akt. Hence, the activation of Akt is
considered to induce O-catenin stabilization in
cytoplasm. Akt is also known to phosphorylate p27,
a cyclin-dependent kinase inhibitor, that arrests the
cell cycle at G0/G1 phase.22),49) Several studies
implicated that the level of p27 protein was increased
in the cell-cycle arrested cells by contact inhibi-
tion.22),23),50),51) On the other hand, down-regulation
of p27 was indicated to lead to failure of contact
inhibition.24),25)
Our study implicated that the ﬁbroblast cells, in
which NEDD4 was exogenously over-expressed,
decreased the amount of p27 and accumulated
cytoplasmic O-catenin through dysregulation of
PTEN. This abnormal regulation contributed to
promote the cell proliferation or invasiveness.
Furthermore, NEDD4 expression led to expression
of ECM components and induced the accumulation
of collagen or ﬁbronectin. These results demon-
strated that NEDD4 over-expressing cells acquired
similar phenotypes as keloid ﬁbroblasts. While TGF-
O/SMAD signaling is known as the regulator of
collagen expression, the mechanisms of accumulation
Fig. 5. Depletion of NEDD4 decreased the expression of collagen and ﬁbronectin. (A) Type 1 or 3 collagen and ﬁbronectin expression
was diminished in NEDD4 knocked down NHDF cells by RT-PCR. (B) The extracellular ﬁbronectin was detected by immunoblot
analysis using cell conditioned culture media. The protein level of ﬁbronectin also decreased in NEDD4 depleted NHDF cells both
extra- and intracellular compartment. CM; conditioned media. (C) The collagen expression was analyzed 72h after transfection of
expression vector. The protein level of collagen was increased in NEDD4 over-expressing NIH3T3 cells than mock cells.
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not fully understood. Our results provide the clue for
the clariﬁcation of the formation of keloid tissues.
We are still puzzled in the relationship between
NEDD4 expression and predisposed individuals of
keloid and the direct regulator of ECM compounds
in NEDD4 signal transduction. Although the ex-
pression level in keloid ﬁbroblasts seemed to be
lower than that in NHDF in Fig. 1A, these in vitro
expression levels may not reﬂect exactly the in vivo
pathological conditions. We need to examine the
expression of NEDD4 using the clinical samples of an
active stage of keloid disease, but biopsy samples at
such stage is extremely diﬃcult to obtain because
biopsy itself becomes the stimuli for cell growth
and may make the keloid disease condition worse.
Although further investigation is required, our study
ﬁrst implies that NEDD4 is functionally related to
keloid formation and suggest that the NEDD4 is a
potential target for treatment and/or prevention of
the keloid disease.
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